IMDX
NASDAQ · Biotechnology
Insight Molecular Diagnostic
$2.31
-0.08 (-3.35%)
Open$2.35
Previous Close$2.39
Day High$2.39
Day Low$2.19
52W High$8.51
52W Low$2.35
Volume—
Avg Volume131.2K
Market Cap81.48M
P/E Ratio—
EPS$-1.49
SectorBiotechnology
Analyst Ratings
Buy
11 analysts
Price Target
+653.7% upside
Current
$2.31
$2.31
Target
$17.41
$17.41
$14.05
$17.41 avg
$26.42
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 4.29M | 2.65M | 22.03M |
| Net Income | -53,073,758 | -29,549,262 | 4.29M |
| Profit Margin | -1,238.5% | -1,176.6% | 19.5% |
| EBITDA | -51,798,365 | -30,441,352 | 9.08M |
| Free Cash Flow | — | — | 3.08M |
| Rev Growth | +61.7% | +61.7% | +9.7% |
| Debt/Equity | — | — | 1.02 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $294.45 | -0.18% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $467.06 | -0.22% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $167.95 | -1.05% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $542.62 | -0.81% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $951.19 | -0.86% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.65 | -2.00% | 7.7 | 20.98B |